Literature DB >> 15973521

Inhaled nitric oxide therapy in adults: European expert recommendations.

Peter Germann1, Antonio Braschi, Giorgio Della Rocca, Anh Tuan Dinh-Xuan, Konrad Falke, Claes Frostell, Lars E Gustafsson, Philippe Hervé, Philippe Jolliet, Udo Kaisers, Hector Litvan, Duncan J Macrae, Marco Maggiorini, Nandor Marczin, Bernd Mueller, Didier Payen, Marco Ranucci, Dietmar Schranz, Rainer Zimmermann, Roman Ullrich.   

Abstract

BACKGROUND: Inhaled nitric oxide (iNO) has been used for treatment of acute respiratory failure and pulmonary hypertension since 1991 in adult patients in the perioperative setting and in critical care.
METHODS: This contribution assesses evidence for the use of iNO in this population as presented to a expert group jointly organised by the European Society of Intensive Care Medicine and the European Association of Cardiothoracic Anaesthesiologists.
CONCLUSIONS: Expert recommendations on the use of iNO in adults were agreed on following presentation of the evidence at the expert meeting held in June 2004.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15973521     DOI: 10.1007/s00134-005-2675-4

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  108 in total

1.  Use of nitric oxide inhalation in chronic obstructive pulmonary disease.

Authors:  K Ashutosh; K Phadke; J F Jackson; D Steele
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

Review 2.  Nitric oxide insufficiency, platelet activation, and arterial thrombosis.

Authors:  J Loscalzo
Journal:  Circ Res       Date:  2001-04-27       Impact factor: 17.367

3.  Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease.

Authors:  Debra L Weiner; Patricia L Hibberd; Peter Betit; Andrew B Cooper; Christine A Botelho; Carlo Brugnara
Journal:  JAMA       Date:  2003-03-05       Impact factor: 56.272

4.  Respective and combined effects of prone position and inhaled nitric oxide in patients with acute respiratory distress syndrome.

Authors:  L Papazian; F Bregeon; F Gaillat; X Thirion; M Gainnier; R Gregoire; P Saux; F Gouin; Y Jammes; J P Auffray
Journal:  Am J Respir Crit Care Med       Date:  1998-02       Impact factor: 21.405

5.  Inhaled nitric oxide for pulmonary hypertension after heart transplantation.

Authors:  A Ardehali; K Hughes; A Sadeghi; F Esmailian; D Marelli; J Moriguchi; M A Hamilton; J Kobashigawa; H Laks
Journal:  Transplantation       Date:  2001-08-27       Impact factor: 4.939

6.  Combination of inhaled nitric oxide and intravenous prostacyclin for successful treatment of severe pulmonary hypertension in a patient with acute respiratory distress syndrome.

Authors:  R Kuhlen; E Walbert; P Fränkel; S Thaden; W Behrendt; R Rossaint
Journal:  Intensive Care Med       Date:  1999-07       Impact factor: 17.440

7.  Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management.

Authors:  D L Moraes; W S Colucci; M M Givertz
Journal:  Circulation       Date:  2000-10-03       Impact factor: 29.690

8.  Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation.

Authors:  C G Frostell; H Blomqvist; G Hedenstierna; J Lundberg; W M Zapol
Journal:  Anesthesiology       Date:  1993-03       Impact factor: 7.892

9.  Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics.

Authors:  D S Celermajer; S Cullen; J E Deanfield
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

10.  Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension.

Authors:  C Girard; J J Lehot; J C Pannetier; S Filley; P Ffrench; S Estanove
Journal:  Anesthesiology       Date:  1992-11       Impact factor: 7.892

View more
  23 in total

1.  Successful treatment of acute respiratory distress syndrome after hysterectomy for life-threatening atonic bleeding by inhaled nitric oxide.

Authors:  Ayaka Fujita; Eiji Hashiba; Noriaki Otomo; Masatoshi Muraoka; Futoshi Kimura; Kazuyoshi Hirota
Journal:  J Anesth       Date:  2011-06-03       Impact factor: 2.078

2.  Adjunctive therapy with inhaled nitric oxide for severe acute chest syndrome in patients with sickle cell disease.

Authors:  Hermann Wrigge; Eduardo L V Costa; Thilo Busch
Journal:  Intensive Care Med       Date:  2015-10-02       Impact factor: 17.440

3.  Inhaled nitric oxide for acute chest syndrome in adult sickle cell patients: a randomized controlled study.

Authors:  B Maitre; M Djibre; S Katsahian; A Habibi; K Stankovic Stojanovic; M Khellaf; I Bourgeon; F Lionnet; A Charles-Nelson; L Brochard; F Lemaire; F Galacteros; C Brun-Buisson; M Fartoukh; A Mekontso Dessap
Journal:  Intensive Care Med       Date:  2015-10-02       Impact factor: 17.440

4.  Practice Variation, Costs and Outcomes Associated with the Use of Inhaled Nitric Oxide in Pediatric Heart Transplant Recipients.

Authors:  David W Bearl; Debra A Dodd; Cary Thurm; Matt Hall; Jonathan H Soslow; Brian Feingold; Justin Godown
Journal:  Pediatr Cardiol       Date:  2018-12-13       Impact factor: 1.655

5.  S3 guidelines for intensive care in cardiac surgery patients: hemodynamic monitoring and cardiocirculary system.

Authors:  M Carl; A Alms; J Braun; A Dongas; J Erb; A Goetz; M Goepfert; W Gogarten; J Grosse; A R Heller; M Heringlake; M Kastrup; A Kroener; S A Loer; G Marggraf; A Markewitz; D Reuter; D V Schmitt; U Schirmer; C Wiesenack; B Zwissler; C Spies
Journal:  Ger Med Sci       Date:  2010-06-15

6.  Prolonged exposure to inhaled nitric oxide does not affect haemostasis in piglets.

Authors:  Johanna Albert; Piotr Harbut; Stanisław Zieliński; Stanisław Ryniak; Caroline Gillis-Haegerstrand; Robert Lindwall; Leszek Solski; Jon O Lundberg; Jan Svensson; Waldemar Goździk
Journal:  Intensive Care Med       Date:  2007-05-12       Impact factor: 17.440

Review 7.  Brazilian recommendations of mechanical ventilation 2013. Part I.

Authors: 
Journal:  J Bras Pneumol       Date:  2014 Jul-Aug       Impact factor: 2.624

Review 8.  Perioperative pharmacological management of pulmonary hypertensive crisis during congenital heart surgery.

Authors:  Nathan Brunner; Vinicio A de Jesus Perez; Alice Richter; François Haddad; André Denault; Vanessa Rojas; Ke Yuan; Mark Orcholski; Xiaobo Liao
Journal:  Pulm Circ       Date:  2014-03       Impact factor: 3.017

Review 9.  Bench-to-bedside review: Inhaled nitric oxide therapy in adults.

Authors:  Benedict C Creagh-Brown; Mark J D Griffiths; Timothy W Evans
Journal:  Crit Care       Date:  2009-05-29       Impact factor: 9.097

Review 10.  Treatment of respiratory failure in COPD.

Authors:  Stephan Budweiser; Rudolf A Jörres; Michael Pfeifer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.